Cure Therapeutics is a startup developing gene and cell therapies in Korea. Its founder David Kim explains where his passion for regenerative therapies stems from, breaks down the main hurdles standing in the way of success and describes how his company’s business model focused on flexibility and development speed through open innovation is especially well-equipped to jump over them.
Gene and cell therapies can completely cure diseases. They can reverse the progression of severe conditions and return patients to a healthy state
